Jashodeep Datta

Jashodeep Datta

University of Miami

H-index: 30

North America-United States

About Jashodeep Datta

Jashodeep Datta, With an exceptional h-index of 30 and a recent h-index of 24 (since 2020), a distinguished researcher at University of Miami, specializes in the field of Surgery, Oncology, Cancer Immunology, Immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Molecular differences with therapeutic implications in early-onset compared to average-onset cholangiocarcinoma.

Abstract C002: Interleukin-1 receptor accessory protein (IL1RAP) overexpression is associated with worse prognosis in PDAC and is targetable by nadunolimab

Abstract C064: Chronic platinum exposure induces cell-intrinsic type1 interferon/STING pathway activation in homologous recombination-deficient pancreatic cancer to drive …

Abstract B093: Alcoholic chronic inflammation driven CREB mediates acinar-to-ductal reprogramming and promote neoplastic progression

Abstract C021: Granulocytic MDSC-derived NLRP3 inflammasome activation is a novel regulator of inflammatory CAF skewness in pancreatic cancer

Abstract C025: Fibroblast-specific IL1R1-p38 MAPK signaling sustains stromal inflammation and contributes to therapeutic resistance in pancreatic cancer

Abstract PR16: Neutrophil-intrinsic tumor necrosis factor (TNF) is a novel driver of T-cell and cancer-associated fibroblast (CAF) dysfunction in pancreatic cancer

CREB activation drives acinar to ductal reprogramming and promote pancreatic cancer progression in animal models of alcoholic chronic pancreatitis

Jashodeep Datta Information

University

Position

Assistant Professor of Surgery Miller School of Medicine | Sylvester

Citations(all)

2538

Citations(since 2020)

1692

Cited By

1453

hIndex(all)

30

hIndex(since 2020)

24

i10Index(all)

58

i10Index(since 2020)

50

Email

University Profile Page

Google Scholar

Jashodeep Datta Skills & Research Interests

Surgery

Oncology

Cancer Immunology

Immunotherapy

Top articles of Jashodeep Datta

Molecular differences with therapeutic implications in early-onset compared to average-onset cholangiocarcinoma.

2024/1/20

Abstract C002: Interleukin-1 receptor accessory protein (IL1RAP) overexpression is associated with worse prognosis in PDAC and is targetable by nadunolimab

Cancer Research

2024/1/16

Jashodeep Datta
Jashodeep Datta

H-Index: 21

Manuel Hidalgo
Manuel Hidalgo

H-Index: 60

Abstract C064: Chronic platinum exposure induces cell-intrinsic type1 interferon/STING pathway activation in homologous recombination-deficient pancreatic cancer to drive …

Cancer Research

2024/1/16

Abstract B093: Alcoholic chronic inflammation driven CREB mediates acinar-to-ductal reprogramming and promote neoplastic progression

Cancer Research

2024/1/16

Abstract C021: Granulocytic MDSC-derived NLRP3 inflammasome activation is a novel regulator of inflammatory CAF skewness in pancreatic cancer

Cancer Research

2024/1/16

Abstract C025: Fibroblast-specific IL1R1-p38 MAPK signaling sustains stromal inflammation and contributes to therapeutic resistance in pancreatic cancer

Cancer Research

2024/1/16

Anna Bianchi
Anna Bianchi

H-Index: 1

Jashodeep Datta
Jashodeep Datta

H-Index: 21

Abstract PR16: Neutrophil-intrinsic tumor necrosis factor (TNF) is a novel driver of T-cell and cancer-associated fibroblast (CAF) dysfunction in pancreatic cancer

Cancer Research

2024/1/16

CREB activation drives acinar to ductal reprogramming and promote pancreatic cancer progression in animal models of alcoholic chronic pancreatitis

bioRxiv

2024

Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer

Oncoimmunology

2024/12/31

Anna Bianchi
Anna Bianchi

H-Index: 1

Jashodeep Datta
Jashodeep Datta

H-Index: 21

Tumor Cell–Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer

Cancer Research

2024/4/15

Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer

Hepatobiliary Surgery and Nutrition

2024/4/4

Jashodeep Datta
Jashodeep Datta

H-Index: 21

CREB-ROCK driven extracellular matrix remodeling exasperates pancreatic cancer progression

Cancer Research

2024/3/22

Patient metabolic profile defined by liver and muscle 18F-FDG PET avidity is independently associated with overall survival in gastric cancer

Gastric Cancer

2024/3/4

Jashodeep Datta
Jashodeep Datta

H-Index: 21

Association of race and CA 19-9 nonproduction with limited pathologic response to neoadjuvant chemotherapy in patients with localized pancreatic cancer.

2024/1/20

Syed A Ahmad
Syed A Ahmad

H-Index: 34

Jashodeep Datta
Jashodeep Datta

H-Index: 21

A phase 1 trial of combined MEK, STAT3 and PD-1 inhibition in metastatic pancreatic ductal adenocarcinoma (PDAC).

2024/1/20

Utility of circulating tumor DNA (ctDNA) for the detection of minimal residual disease (MRD) after curative-intent therapy for patients with localized pancreatic adenocarcinoma …

2024/1/20

Jashodeep Datta
Jashodeep Datta

H-Index: 21

Dovitinib restricts EMT and promotes T cell recruitment to immune-desert gastric cancers via tumor-intrinsic IFN-γ signaling

Cancer Research

2023/4/4

Texture Analysis Identifies Distinct Radiomic Signals Associated with Survival in Hispanic Patients with Pancreatic Cancer

Annals of surgical oncology

2023/4

ASO Visual Abstract: Racial Disparity in Pathologic Response Following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer–A Multi-institutional Analysis from the Central …

Annals of surgical oncology

2023/3/1

ASO Author Reflections: Racial Disparities in Chemoresponsivity in Localized Pancreatic Cancer: Nature or Nurture?

Annals of surgical oncology

2023/3

Jashodeep Datta
Jashodeep Datta

H-Index: 21

See List of Professors in Jashodeep Datta University(University of Miami)